Northern Trust’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
IC
CCM
SS
Northern Trust's FTH Position: Q2 2025 in Review
Northern Trust sold out of Faeth Therapeutics (FTH) in Q2 2025, closing a stake of 1,299 shares — an estimated $10.2K sold.
Northern Trust first reported a position in FTH in Q1 2021 and held it in 17 quarters. The position peaked at $1.69M in Q3 2021. 10 funds tracked by Wall St. Rank hold FTH as of Q2 2025.
- Northern Trust reported no remaining Faeth Therapeutics position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 1,299 Faeth Therapeutics shares in Q2 2025, an estimated $10.2K.
- Northern Trust first reported a position in Faeth Therapeutics in Q1 2021 and held it in 17 quarters.
- Northern Trust's Faeth Therapeutics position peaked at $1.69M in Q3 2021.
- 10 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.